Fc Optimization of Therapeutic Antibodies Enhances Their Ability to Kill Tumor Cells in Vitro and Controls Tumor Expansion in Vivo via Low-Affinity Activating Fc Receptors

Cancer Research - United States
doi 10.1158/0008-5472.can-07-0696
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Fc Gamma Receptors: Glycobiology and Therapeutic Prospects

Journal of Inflammation Research
AllergyImmunology
2016English

Therapeutic Fc-Fusion Proteins and Peptides as Successful Alternatives to Antibodies

mAbs
AllergyImmunology
2011English

Pentraxins and Fc Receptors

Immunological Reviews
AllergyImmunology
2012English

Ethynyldeoxyuridine (EdU) Suppresses in Vitro Population Expansion and in Vivo Tumor Progression of Human Glioblastoma Cells

Journal of Neuro-Oncology
Cancer ResearchOncologyNeurology
2011English

Introduction of B-Chain-Inactivated Ricin Into Mouse Macrophages and Rat Kupffer Cells via Their Membrane Fc Receptors

Journal of Experimental Medicine
MedicineAllergyImmunology
1976English

Knock Down of HIF-1α in Glioma Cells Reduces Migration in Vitro and Invasion in Vivo and Impairs Their Ability to Form Tumor Spheres

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2010English

Activating and Inhibitory IgG Fc Receptors on Human DCs Mediate Opposing Functions

Journal of Clinical Investigation
Medicine
2005English

Follicular Dendritic Cells and the Persistence of HIV Infectivity: The Role of Antibodies and Fc Receptors

Journal of Immunology
AllergyImmunology
2002English

The Role of Fc Gamma Receptors in the Activity of Immunomodulatory Antibodies for Cancer

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy